AbbVie (ABBV) Shares Outstanding (2012 - 2026)

AbbVie (ABBV) has reported Shares Outstanding (Entity) for 15 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.03% year-over-year to $1.8 billion in Q2 2026; TTM through Jun 2026 was $1.8 billion, a 0.03% change from a year earlier, with the FY2025 full-year figure at $1.8 billion, changed 0.16% from the prior year.
• Shares Outstanding (Entity) was $1.8 billion for Q2 2026 at AbbVie, roughly flat from $1.8 billion in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.8 billion in Q4 2022 and troughed at $1.8 billion in Q1 2023.
• A 5-year average of $1.8 billion and a median of $1.8 billion in 2025 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) retreated 0.17% in 2023 and climbed 0.16% in 2025, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $1.8 billion in 2022, then retreated by 0.17% to $1.8 billion in 2023, then declined by 0.06% to $1.8 billion in 2024, then increased by 0.16% to $1.8 billion in 2025, then decreased by 0.06% to $1.8 billion in 2026.
• The last three Shares Outstanding (Entity) figures came in at $1.8 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.